According to GlobalData’s company profile on Syros Pharmaceuticals, Cancer treatment biomarkers was a key innovation area identified from patents. Syros Pharmaceuticals‘s grant share as of February 2024 was 26%. Grant share is based on the ratio of number of grants to total number of patents.
Cdk7 inhibitors for treating cancer and other diseases
The granted patent (Publication Number: US11918592B2) discloses a compound of Formula I and its various derivatives, including pharmaceutically acceptable salts, stereoisomers, or isotopic forms. The compound is designed to target aberrant activity of CDK7, offering a method for treating diseases associated with such activity. The patent covers a pharmaceutical composition comprising the compound and a method of administering it to patients suffering from proliferative diseases, infectious diseases, or diseases caused by expanded repeats of simple nucleotide tracts.
Furthermore, the patent details the specific diseases that can be targeted by the compound, including various types of cancers such as blood cancer, bone cancer, brain cancer, breast cancer, lung cancer, melanoma, neuroblastoma, and ovarian cancer. The method also includes the option of administering a second agent alongside the compound, which can be an anti-proliferative agent, an anti-cancer agent, an immunosuppressant, or a pain-relieving agent. Overall, the patent provides a comprehensive approach to treating a range of diseases associated with CDK7 activity, offering potential therapeutic options for patients with different types of conditions.
To know more about GlobalData’s detailed insights on Syros Pharmaceuticals, buy the report here.
From 
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies